Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

6.820 -0.090 (-1.30%)
Streaming Delayed Price Updated: 2:26 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,129,389
Open 6.900
Bid (Size) 6.810 (26)
Ask (Size) 6.820 (30)
Prev. Close 6.910
Today's Range 6.720 - 6.910
52wk Range 3.060 - 6.970
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Chart Of The Day: ADMA Biologics - Hitting New Highs
100% technical buy signals 8 new highs and up 7.24% in the last month 110.10+ Weighted Alpha 
Via Talk Markets
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
Conference Call Scheduled for May 9, 2024, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire

Performance

YTD
+49.89%
+49.89%
1 Month
+9.65%
+9.65%
3 Month
+29.41%
+29.41%
6 Month
+84.82%
+84.82%
1 Year
+94.86%
+94.86%

More News

Read More
A Closer Look at 6 Analyst Recommendations For ADMA Biologics
Via Benzinga
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
Forecasting The Future: 4 Analyst Projections For ADMA Biologics
Via Benzinga
Recap: ADMA Biologics Q4 Earnings
Via Benzinga
Earnings Preview For ADMA Biologics
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For ADMA Biologics
Via Benzinga
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces CFO Transition
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Preview: ADMA Biologics
Via Benzinga
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Adma Biologics Stock Crushed the Market on Friday
Via The Motley Fool
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Adma Biologics Was Trouncing the Market Today
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Shares of ADMA Biologics Are Climbing Thursday
Via The Motley Fool
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.